The combined effect of antiEGFR antiVEGF and therapy in combination with the pr Operative chemoradiotherapy for rectal cancer remains unknown, but given the negative results for the combined EGFR and VEGF blockade in patients with metastatic colorectal cancer in combination with chemotherapy, is studies of this avenue unlikely. Blaszkowsky et al. led a small study investigate the combination of bevacizumab, erlotinib and 5-FU with RT in patients with locally advanced rectal cancer. The program proved to be well tolerated Affectionate and very active with a pCR rate of 47% and may deserve further examination. However, the value of PCR as a replacement for DFS and OS is uncertain. SGX-523 6th Conclusion Anti-EGFR monoclonal go Are among the standard treatment for patients with metastatic colorectal cancer due to their proven effectiveness. It is now clear that the benefits antiEGFR monoclonal rpern Of patients with KRAS WT tumors isolated. It seems that the mutation status of the KRAS gene only the beginning of our amplifier Ndnis of EGFR is an integral part of the biology of CRC. react as a subset of patients, the treatment antiEGFR, there is a need for a better Pr predictors for the selection of patients for such therapy lead.
Several key elements of the signaling pathway of EGFR were detected, including normal BRAF, PTEN, Akt and PI3K, which deserve further study as Pr Predictors of response to existing treatments or a new intervention targets. The unexpected result with adverse blocking EGFR and VEGF combined connected is a reminder of how much there to learn. New combinations and new agents continue to light up the fa Vergie S You overcome resistance to EGFR pathway inhibitors, and we hope that the new targets are identified. Further investigation of the fa Use our knowledge of EGFR pathway inhibitors, the results must be improved in the adjuvant and neoadjuvant treatment justified.
The small genome of the virus in comparison to other agencies required to appropriate cellular Re machinery to abzuschlie their replication cycle S. For example, not all virus code nucleic Acid and protein components for the translation of viral mRNA and thus autonomous viruses use different mechanisms required and h Frequently complex to reverse the cellular Re translation device to their advantage. Many important discoveries in the field of research on the application of studies of viral mRNAs, such as the description of the sites internal ribosome entry site, the knowledge that the efficient initiation of translation is done by forming a closed loop, and identification of Unweighted Hnlichen events, expand the directories genetic translation by ribosomal frameshifting Read Translation of Man vers and leaky scanning.
The use of alternative mechanisms of translation by viral pathogens k Can be critical to the resis-Ma Took against cellular Ren innate antiviral responses, such as avoidance or inhibition of global translation repression mediated by protein kinase A activation. The important link between viral replication and cellular Rer Translation is especially evident with viruses containing a positive-strand RNA genome. These viruses. With the notable exception of retroviruses, generally not encapsulated RNA replication proteins, And therefore an important first step in the virus life cycle after entering the translation of viral mRNA is Thus, studies that can be on the molecular mechanisms of mRNA translation and its impact on viral replication turn out new targets for antiviral drugs.